
47 million-year-old bug is the oldest singing cicada fossil from Europe
Scientists recently described the insect as a new genus and species, using this fossil and one other that was nearly as well preserved, from the same site. Even though the specimens are female, their location on the cicada family tree suggests that males of this species could sing as modern cicadas do. Found in Germany decades ago, their presence there reveals that singing cicadas dispersed in Europe millions of years earlier than once thought.
The fossils are also the oldest examples of 'true' singing cicadas in the family Cicadidae, researchers reported April 29 in the journal Scientific Reports. Most modern cicadas belong to this family, including annual cicadas that appear every summer worldwide, as well as broods of black-bodied and red-eyed periodical cicadas, which emerge from May to June in eastern North America in cycles of 13 or 17 years. Brood XIV, one of the biggest broods, emerges across a dozen US states this year. Cicadas are found on every continent except Antarctica, and there are more than 3,000 species.
The fossil record for insects in general is abundant in just a few dozen locations, and while modern cicada species are numerous today, paleontologists have documented only 44 Cicadidae fossils. The earliest definitive fossil of a singing cicada was discovered in Montana and dates from 59 million to 56 million years ago, said lead study author Dr. Hui Jiang, a paleontologist and researcher with the Bonn Institute of Organismic Biology at the University of Bonn in Germany. Its newly described relative is the earliest singing cicada from Europe, Jiang told CNN in an email.
Related card
Cicadas rising: A visual guide to 2024's rare dual appearance
Because the body structures of the European fossils were so well preserved, scientists were able to assign the ancient insect to a modern tribe of cicadas called Platypleurini, 'which is today primarily distributed in tropical and subtropical regions of sub-Saharan Africa and Asia, but is absent from Europe,' Jiang said.
Prior research suggested that this lineage evolved in Africa about 30 million to 25 million years ago and dispersed from there, according to Jiang. 'This fossil pushes back the known fossil record of sound-producing cicadas in the tribe Platypleurini by approximately 20 million years, indicating that the diversification of this group occurred much earlier than previously recognized,' the researcher added.
The discovery hints that this group of cicadas evolved more slowly than prior estimates from molecular data proposed, said Dr. Conrad Labandeira, a senior research geologist and curator of fossil arthropods at the Smithsonian Museum of Natural History in Washington, DC.
'This suggests that older fossils of the Platypleurini are yet to be discovered,' said Labandeira, who was not involved in the research. 'Such discoveries would assist in providing better calibrations for determining a more realistic evolutionary rate.'
Researchers named the cicada Eoplatypleura messelensis. Its name refers to where the specimens were discovered: the Messel Pit in Germany, a rich fossil site dating to the Eocene epoch (57 million to 36 million years ago). Excavated in the 1980s, the fossils have since been in the collection of the Senckenberg Research Institute and Natural History Museum Frankfurt in Germany, said senior study author Dr. Sonja Wedmann, head of Senckenberg's paleoentomology department.
A very deep volcanic lake, with a bottom where no oxygen penetrated, once filled the Messel Pit. That environment created ideal conditions for fossilization, and fine-grain sediments from this former lake bed hold a variety of Eocene life, Wedmann told CNN in an email.
'The excellent preservation not only of insects, but of all groups of organisms, is the reason why Messel is an UNESCO world heritage site,' a designation it earned in 1995, Wedmann said.
The more complete of the two cicada fossils 'is one of the best preserved insects from the Messel pit fossil site,' Wedmann added. 'Senckenberg has a collection of over 20,000 fossil insects from Messel, and among these it stands out because of its really beautiful and complete preservation.'
In its overall head and body shape, E. messelensis strongly resembles modern cicadas. Its rostrum — a snoutlike mouth — is intact, but closer analysis is needed to tell whether it used the rostrum for feeding on plant tissues called xylem, as most modern cicadas do, Labandeira said.
E. messelensis also shows hints of colors and patterns in its wings. This feature camouflages modern cicadas as they cling to tree trunks, and it may have served a similar purpose for E. messelensis, according to Jiang.
However, E. messelensis differs from modern cicadas in subtle ways. For example, its forewings are broader and less elongated than those of species alive today, which may have affected how it flew.
Would the ancient cicada's call have sounded like those of its modern relatives? 'We can't know the exact song,' Jiang said. However, based on the cicada's body shape and placement in the singing cicada group, 'it likely produced sounds similar in function to modern cicadas.'
When Brood XIV emerges in the billions in the late spring and early summer of 2025, their calls will measure from 90 to 100 decibels — as loud as a subway train. Other types of cicadas produce an even bigger ruckus: Songs of the African cicada Brevisana brevis peak at nearly 107 decibels, about as loud as a jet taking off.
The volume of the ancient species' songs may have been even louder than that, Jiang said. The abdomen of E. messelensis is broader and larger than those of its modern relatives, suggesting that males could have had a larger resonating cavity. This cavity may have amplified sound from the vibrating structures in their abdomens, called tymbals, to produce a louder buzz.
'Of course, this is only a hypothesis,' Jiang added. 'Future studies on how morphology relates to sound production in modern cicadas will help to test it.'
Mindy Weisberger is a science writer and media producer whose work has appeared in Live Science, Scientific American and How It Works magazine.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
an hour ago
- Medscape
Safe to Skip Postop Radioiodine in Low-Risk Thyroid Cancers?
TOPLINE: A recent phase 3 trial found that 5-year recurrence-free survival was similar among patients who did and did not receive postoperative radioiodine, indicating the treatment can be safely avoided in patients with low-risk differentiated thyroid cancer — specifically those with pT1, pT2, and N0 or Nx tumors who have no adverse features after total thyroidectomy. METHODOLOGY: Although now used less often, total thyroidectomy followed by radioiodine has traditionally been the standard of care for treating differentiated thyroid cancer. Observational studies and the ESTIMABL2 trial , published in 2022, suggested that patients with low-risk disease could safely skip radioiodine, but confirmatory evidence was still needed. The recent randomized, noninferiority, phase 3 IoN trial aimed to answer this question. The study involved patients at 33 cancer centers in the UK who underwent complete resection following total thyroidectomy and stage pT1, pT2, pT3, or pT3a disease. Researchers randomly assigned 504 patients (77% women) to receive (n = 253) or not receive (n = 251) postoperative radioiodine. Patients underwent neck ultrasound scans annually and serum thyroglobulin measurements every 6 months. The median follow-up was 6.7 years. The primary outcome was 5-year disease-free survival, defined as the absence of locoregional recurrent or residual structural disease, distant metastases, or death from thyroid cancer. Noninferiority was assessed with a margin of 5 percentage points. Overall, 47% of patients had pT1 tumors, 44% had pT2, and 9% had pT3 or pT3a; 91% of patients had N0 or Nx disease, and 9% had N1a disease. TAKEAWAY: Overall, 17 recurrences were reported — 8 in the no-radioiodine group and 9 in the radioiodine group. The 5-year recurrence-free rate was 97.9% in the no-radioiodine group vs 96.3% in the radioiodine group, with an absolute risk difference of 0.5 percentage points (P for noninferiority = .033), highlighting the noninferiority of omitting radioiodine. Higher recurrence rates were observed in patients with pT3 or pT3a tumors than in those with pT1 or pT2 tumors (9% vs 3%) and in patients with N1a tumors than in those with N0 or Nx tumors (13% vs 2%). Additionally, baseline postsurgical thyroglobulin levels ≥ 2 ng/mL were associated with a higher risk for recurrence (hazard ratio, 12.75; P < .0001). Adverse events were comparable between the no-radioiodine and radioiodine groups, with fatigue (25% vs 28%), lethargy (14% in both), and dry mouth (10% vs 9%) being the most common. No treatment-related deaths or deaths from thyroid cancer were reported. But a total of eight patients died — an equal number in both groups. In the no-radioiodine group, deaths were due to two new primary cancers, one myocardial infarction, and one liver failure. In the radioiodine group, one death was due to bowel cancer and three due to vascular or unknown causes. IN PRACTICE: IoN and ESTIMABL2 together 'offer strong and complementary evidence showing' that postoperative radioiodine can be avoided in patients with low-risk differentiated thyroid cancer — more specifically, pT1 or pT2 tumors with N0 nodal status and no other adverse features, the study authors concluded. Although the evidence for or against radioiodine in patients with pT3, pT3a, or N1a tumors was deemed 'insufficient,' the authors concluded that 'most patients worldwide with low-risk differentiated thyroid cancer' can now safely avoid radioiodine. SOURCE: This study, led by Ujjal Mallick, Freeman Hospital, Newcastle upon Tyne, England, was published online in The Lancet. LIMITATIONS: Patients had relatively few recurrences, and the findings may not be applicable to the youngest patients. Additionally, molecular data (eg, on BRAF and TERT mutations) were not routinely collected from patients. DISCLOSURES: This study was funded by Cancer Research UK. One author reported receiving honoraria from Esai and the British Medical Ultrasound Society for presenting treatment options for differentiated thyroid cancer. Another author reported receiving honoraria from Esai for presenting treatment options for differentiated thyroid cancer. All other authors declared having no competing interests. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Medscape
an hour ago
- Medscape
ILD Associated With Increased Risk for Lung Cancer
TOPLINE: Individuals with interstitial lung disease (ILD) had more than a 13-fold higher incidence rate of lung cancer than those without ILD. The association persisted after adjustment for confounders, was consistent across all histological subtypes, and remained elevated even 10 years after ILD diagnosis. METHODOLOGY: ILD is a progressive chronic lung disease previously linked to a suspected incidence of lung cancer. However, no study has comprehensively analyzed the risk for lung cancer in patients with ILD after controlling for genetic factors. This cohort study included 5,425,976 individuals (51.2% men) from the Swedish Total Population Register; of these, 14,624 had ILD (58.1% men; 65.9% aged > 40 years). The researchers conducted a sibling‐controlled analysis to account for genetic and early environmental factors. This involved 9157 individuals with ILD and at least one full sibling and 21,725 unaffected full siblings. The primary outcome was lung cancer diagnosis. The follow-up spanned from 1987 to 2016. TAKEAWAY: The incidence rate of lung cancer was significantly higher among patients with vs without ILD (355.4 vs 26.2 per 100,000 person-years). After adjusting for confounders, the risk for lung cancer remained higher among individuals with ILD (hazard ratio [HR], 2.16). The sibling-controlled analysis also revealed a higher risk for lung cancer (HR, 2.91). When stratified by histological subtypes, an elevated risk for lung cancer was observed for adenocarcinoma (HR, 1.60), squamous cell carcinoma (HR, 2.56), and small cell carcinoma (HR, 3.29). Including the first 3 years of follow-up, ILD was associated with a higher risk for lung cancer, and this increased risk persisted even 10 years post-diagnosis (HR, 2.08). IN PRACTICE: 'Our findings indicate that ILD is associated with an elevated risk of lung cancer, even after adjusting for familial factors' and 'an increased risk of various histological subtypes of lung cancer,' the authors wrote. 'These findings suggest that the presence of ILD should be incorporated into lung cancer risk assessment models,' they added. SOURCE: This study, led by Hui Xu, MD, Karolinska Institutet, Stockholm, Sweden, was published online in JAMA Network Open. LIMITATIONS: The study lacked detailed smoking history and relied on diagnoses of smoking-related diseases as proxies, which may have led to residual confounding. The number of lung cancer cases in some ILD subtypes was too small for detailed subtype-specific analyses. Additionally, the study could not assess tumor location, limiting anatomical correlation between ILD and lung cancer. DISCLOSURES: This study was supported by a grant from the Swedish Cancer Society. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Fast Company
an hour ago
- Fast Company
We designed shade out of our cities. We can design it back in
As I write these words, a heat wave is sweeping through Europe. Last month, a heat wave swept through the East Coast. Next month, a heat wave might sweep through the Middle East, or South Asia, or North Africa. As temperatures continue to reach record highs—and climate change increases the likelihood of heat waves—the sun has become foe, and shade has become king. Shade can lower the ambient temperature of the air by as much as 15 to 20 degrees Fahrenheit. It can cool surfaces by as much as 45 degrees. But where is it? Ten thousand years ago, more than half of the land on Earth was shaded by tree canopies. Today, after millennia of deforestation, agriculture, and urbanization, that number has dropped to just 30%. The problem is particularly dire in cities: A recent map by UCLA and the nonprofit American Forests revealed staggering 'shade deserts' in almost every major urban region in the U.S. According to journalist and author Sam Bloch, this dearth of shade is by design. In his new book, simply titled Shade, Bloch argues that the absence of shade from our lives is not an accident. 'Shade has been deliberately designed out of our environments,' he tells me on a recent phone call. 'Those decisions may have made sense in the past, but we are rapidly moving into a new world where sun protection is going to be as important as sun access.' Shade as old as time Humans have sought shade for as long as we have lived under the sun. 'Forget palm trees and ponds,' Bloch writes. 'In ancient Mesopotamia, cities were the real oases.' Four thousand years ago, in places where temperatures could soar up to 130 degrees, Sumerians used city walls for shade. They built deep, narrow streets and packed houses close together. Unlike modern cities, which are laid out along the cardinal directions, Sumerians also oriented their cities diagonally, which offered equal amounts of sun and shade on both sides of the street. In his book, Bloch mentions the work of Mary Shepperson, a U.K. archaeologist who specializes in urban archaeology of the Middle East. After modeling the sun's daily and seasonal paths over Mesopotamian cities, Shepperson found that the orientation of streets, their narrowness, and small protrusions like vertical rooftop parapets and horizontal eaves likely made for pleasant, shaded cities. The 'wisdom of shade,' as Bloch calls it, was known to the Syrians, Phoenicians, and Persians. Later, it was embraced by the Greeks and Romans, and eventually exported by the Islamic caliphate to modern-day Spain and Portugal. But that is the extent it traveled. Europeans had their own beliefs about what makes a healthy city, and they exported those beliefs to the New World. 'In temperate climates, the sun was their friend, not their enemy,' Bloch writes. 'They had little use for shade.' How we designed shade out of our cities If shade is as old as time, so are our preconceptions against it. Over 2,000 years ago, the Greek philosopher Onesicritus taught that shade stunted growth. As Bloch points out, our prejudice against shade even shines through in the language we use: When something is dubious, it's shady. When we feel offended, we take umbrage. Americans, perhaps more so than others, take particular umbrage at shade. 'We think shade is yucky. It's for damp corners and fetid ponds,' Bloch writes. This goes back to the early colonizing days. When Europeans arrived in modern-day America, they brought with them a 'deep and abiding fear of forests,' which were considered pagan and unholy. In 1771, an English patrician proclaimed 'a garden in a street is not less absurd than a street in a garden.' Or as the author puts it: 'A city dweller who planted trees in their front yard was just another country bumpkin.' Many factors further contributed to the downfall of shade, but perhaps the most significant of them is our ancestors' fear of tuberculosis. Early research from the 1900s showed that bacteria could be killed with sunlight. This understanding birthed a fixation for sunlight that translated to some of the most famous modernist buildings of the time, including Alvar and Aino Aalto's Paimio Sanatorium in Finland. In the U.S., urban planners introduced zoning that called for 'setbacks.' They wrote 'solar codes' into urban plans. They widened roads (which also helped cars thrive) and carved out paths for sunlight to reach deep into the streets. 'This fear of tuberculosis has driven so much of our urban design,' Bloch tells me. The approach trickled down to buildings, as architects clad office buildings and homes with large expanses of glass. Le Corbusier declared glass the foundational material of modernism. Ludwig Mies van der Rohe famously said, 'It's up to the engineers to find some way to stop the heat from coming in or going out,' about his Farnsworth House. Glass, we know now, is notorious for trapping heat. But it has survived as a material of choice, thanks to another notorious invention: AC. Modern air-conditioning was invented in 1902 by American engineer Willis Carrier, who designed a system to control humidity at a printing plant in Brooklyn, New York. Suddenly, external shading systems like brise-soleils, awnings, sun sails—systems that have been used in European cities for centuries—were dismissed as costly add-ons that could never match the level of comfort provided by cool air being fanned through your house. Case in point: After the Truman administration renovated the White House in the 1950s—installing mechanical cooling in the process—it foolishly took down the stripy summer awnings that once kept it cool. Air-conditioning revolutionized cooling around the world, but as Bloch writes, 'it came at a cost.' It distanced us from nature and trapped us inside climate-controlled boxes. It lowered our comfort level and our defenses. Even worse: It exacerbated the heat problem it's supposed to solve by sucking the hot air from our houses and expelling it in our cities. According to computer simulations from Paris and Phoenix, the waste heat from AC units makes the surrounding air about 2 to 3 degrees warmer. 'All this happened when we turned our backs on shade,' Bloch writes. How we can design shade back into our cities So, how do we learn to love shade again? The good news is that there's no need to reinvent the wheel. In his book, Bloch highlights examples from cities all over the world. In Bologna and Singapore alike, people can walk under miles of covered sidewalks that are carved out of the ground floors of buildings. Italians call them portici (porticoes). In Singapore, they're known as 'five-foot ways.' In Seville—where seats at the bullring cost two to three times more when they're in the shade—practically all windows are shaded by roller blinds, or persianas de esparto, which are threaded grass curtains that Sevillanos drape over their balconies. Every spring, the Spanish city also installs toldos over streets and plazas. These 'sun sails' have been used for so long (over 500 years) that they have become a proud tool in the city's shade vernacular. Naturally, every city's 'shade tool kit' will vary based on its climate policy, geographic and socioeconomic conditions, and affinity for design-led solutions. Barcelona has set up 'climate shelters,' while Dallas has been planting thousands of trees. And Los Angeles has been coating its streets and roofs with solar reflective paint. Since the early 2000s, architects have been pushing for more passive houses. But as Bloch writes, the incentives largely benefit the future occupants, whose energy bills are lowered, not the developers, whose bottom lines remain the same whether or not a building is climate-resilient. This 'split incentive' problem has notably hampered construction and can only be solved if cities implement stronger building codes and grant developers stronger financial incentives. (Building a passive house typically costs around 10% more.) Perhaps it would help shift our perception of shade if cities classified heat as an environmental hazard, like water or air pollution. The Clean Water Act limited what industries and farms could dump into waterways. The Clean Air Act required power plants and factories to monitor, control, and report their emissions. A similar requirement for heat might help us take more actionable steps toward heat mitigation. 'If we ever agree that heat is a threat to our freedom and happiness, then we might also decide that shade, our defense against it, is an inalienable right,' Bloch writes. (Even if studies have shown the cooling benefits of shade, Bloch says there is no single, widely accepted index to measure shade's thermal impact.) For Bloch, the problem with shade access isn't necessarily technological but psychological. Some of the experts he interviewed for the book are even calling for a life 'after comfort'—where architecture is made more porous, and where we can learn to live with heat. Studies have found that people who are forced to deal with heat can tolerate it more than those who can escape it. In the U.S., the ideal indoor temperature ranges between 73 and 78 degrees. In Ouagadougou, Burkina Faso—where AC is virtually nonexistent—studies say that the Burkinabe people's ideal temperature is closer to 86. Similar studies have shown that people in Marrakech, Morocco, are more likely to feel comfortable than people in Phoenix, Arizona, despite a similar climate. Bloch knows that the cooling effect provided by shade is never going to replace the icy blast of AC. 'Even on a thermodynamic level, it's not doing the same thing,' he tells me. 'But if we can adjust our expectations as to what comfort really is, we might be able to be more tolerant of shade as a viable solution.'